Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation

PURPOSE: Naloxegol, an oral once-daily peripherally acting mu-opioid receptor antagonist, is indicated for the treatment of opioid-induced constipation (OIC) with inadequate response to laxative(s), in cancer and non-cancer patients. This study mainly aimed to assess in real-life conditions the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemaire, Antoine, Pointreau, Yoann, Narciso, Bérengère, Piloquet, François-Xavier, Braniste, Viorica, Sabaté, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549935/
https://www.ncbi.nlm.nih.gov/pubmed/34120247
http://dx.doi.org/10.1007/s00520-021-06299-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549935/
https://www.ncbi.nlm.nih.gov/pubmed/34120247
http://dx.doi.org/10.1007/s00520-021-06299-2

Ejemplares similares